Veterinary Medicines Information website

Elanco Febantel - Pyrantel 15 mg/ml + 5 mg/ml Suspension zum Eingeben für junge Hunde und Hundewelpen

Authorised
  • Pyrantel embonate
  • Febantel
Download as PDF

Product identification

Medicine name:
Elanco Febantel - Pyrantel 15 mg/ml + 5 mg/ml Suspension zum Eingeben für junge Hunde und Hundewelpen
Active substance:
  • Pyrantel embonate
  • Febantel
Target species:
  • Dog
  • Dog (puppy)
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Pyrantel embonate
    14.40
    milligram(s)
    /
    1.00
    millilitre(s)
  • Febantel
    15.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral suspension
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AF02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Germany
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Informed Consent application (Article 21 of Regulation (EU) 2019/6)
Marketing authorisation holder:
  • Elanco GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Vetoquinol Biowet Sp. z o.o.
  • KVP Pharma+Veterinaer Produkte GmbH
Responsible authority:
  • Federal Office Of Consumer Protection And Food Safety
Authorisation number:
  • V7026815.00.00
Date of authorisation status change:
Informed consent reference:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 16/09/2026
Download